Trader’s Buzz: Repros Therapeutics (RPRX), Tekmira Pharmaceuticals (TKMR), Intercept Pharmaceuticals (ICPT), AAC Holdings (AAC)

Shares of Repros Therapeutics Inc. (RPRX) spiked more than 38 percent just after the opening bell on Friday, after the company reported it held a “constructive” meeting with the FDA regarding a potential Androxal NDA filing. Repros said that based on the data compiled to date, the FDA did not identify any additional clinical studies […] View the full post at: Trader’s Buzz: Repros Therapeutics (RPRX), Tekmira Pharmaceuticals (TKMR), Intercept Pharmaceuticals (ICPT), AAC Holdings (AAC) No related posts.